Stronghold Plus


selamectin / sarolaner

This medicine is authorised for use in the European Union.


This is a summary of the European public assessment report (EPAR) for Stronghold Plus. It explains how the Agency assessed this veterinary medicine to recommend its authorisation in the European Union (EU) and its conditions of use. It is not intended to provide practical advice on how to use Stronghold Plus.

For practical information about using Stronghold Plus, animal owners or keepers should read the package leaflet or contact their veterinarian or pharmacist.

This EPAR was last updated on 20/12/2021

Authorisation details

Product details
Stronghold Plus
Agency product number
Active substance
  • selamectin
  • sarolaner
International non-proprietary name (INN) or common name
  • selamectin
  • sarolaner
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Zoetis Belgium SA
Date of issue of marketing authorisation valid throughout the European Union
Contact address

Rue Laid Burniat 1
1348 Louvain-la-Neuve

Product information

07/12/2021 Stronghold Plus - EMEA/V/C/004194 - R/0008

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

  • Antiparasitic products, insecticides and repellents

  • Macrocyclic lactones

  • combinations

Therapeutic indication

For cats with, or at risk from, mixed parasitic infestations by ticks and fleas, lice, mites, gastrointestinal nematodes or heartworm.

The veterinary medicinal product is exclusively indicated when use against ticks and one or more of the other target parasites is indicated at the same time.

Assessment history

How useful was this page?

Add your rating
2 ratings
1 rating
2 ratings